PT95111A - Processo para a preparacao de proteinas de fusao - Google Patents

Processo para a preparacao de proteinas de fusao

Info

Publication number: PT95111A
Authority: PT; Portugal
Prior art keywords: proteins; manner; fuseo; preparation; fusion protein
Prior art date: 1989-08-29

Application number

PT95111A

Other languages

English (en)

Other versions

PT95111B (pt

Inventor

Brian Seed

Siegfried Stengelin

Wolfgang Ulmer

Paul Haberman

Eugen Uhlmann

Original Assignee

Hoechst Ag

Gen Hospital Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-08-29

Filing date

1990-08-28

Publication date

1991-05-22

1990-08-28 Application filed by Hoechst Ag, Gen Hospital Corp filed Critical Hoechst Ag

1991-05-22 Publication of PT95111A publication Critical patent/PT95111A/pt

1998-10-30 Publication of PT95111B publication Critical patent/PT95111B/pt

Links

108090000623 proteins and genes Proteins 0.000 title abstract 3
102000004169 proteins and genes Human genes 0.000 title abstract 2
102000037865 fusion proteins Human genes 0.000 abstract 3
108020001507 fusion proteins Proteins 0.000 abstract 3
108091034117 Oligonucleotide Proteins 0.000 abstract 2
239000000470 constituent Substances 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
239000013612 plasmid Substances 0.000 abstract 1
230000001105 regulatory effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

Health & Medical Sciences (AREA)
Genetics & Genomics (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
General Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Wood Science & Technology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Chemistry (AREA)
Physics & Mathematics (AREA)
Gastroenterology & Hepatology (AREA)
Toxicology (AREA)
Plant Pathology (AREA)
Endocrinology (AREA)
Microbiology (AREA)
Diabetes (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

PT95111A 1989-08-29 1990-08-28 Processo para a preparacao de proteinas de fusao PT95111B (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US39987489A	1989-08-29	1989-08-29

Publications (2)

Publication Number	Publication Date
PT95111A true PT95111A (pt)	1991-05-22
PT95111B PT95111B (pt)	1998-10-30

Family

ID=23581315

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT95111A PT95111B (pt)	1989-08-29	1990-08-28	Processo para a preparacao de proteinas de fusao

Country Status (19)

Country	Link
EP (1)	EP0489780B1 (pt)
JP (1)	JP3043803B2 (pt)
KR (1)	KR0159786B1 (pt)
AT (1)	ATE173018T1 (pt)
AU (1)	AU638277B2 (pt)
CA (1)	CA2065146C (pt)
CY (1)	CY2168B1 (pt)
DE (1)	DE69032743T2 (pt)
DK (1)	DK0489780T3 (pt)
ES (1)	ES2124216T3 (pt)
FI (1)	FI113183B (pt)
GR (1)	GR1005153B (pt)
HU (1)	HU216069B (pt)
IE (1)	IE903120A1 (pt)
IL (1)	IL95495A (pt)
NO (1)	NO308667B1 (pt)
PT (1)	PT95111B (pt)
WO (1)	WO1991003550A1 (pt)
ZA (1)	ZA906839B (pt)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5426036A (en) *	1987-05-05	1995-06-20	Hoechst Aktiengesellschaft	Processes for the preparation of foreign proteins in streptomycetes
ATE148710T1 (de) *	1992-12-02	1997-02-15	Hoechst Ag	Verfahren zur gewinnung von proinsulin mit korrekt verbundenen cystinbrücken
ATE203998T1 (de) *	1993-04-27	2001-08-15	Hoechst Ag	Amorphe monosphärische formen von insulinderivaten
DE69435058T2 (de) *	1993-10-05	2008-04-30	Asahi Glass Co., Ltd.	Multicloning-vektor, expressionsvektor und herstellung von fremdproteinen unter verwendung des expressionsvektors
US6001604A (en) *	1993-12-29	1999-12-14	Bio-Technology General Corp.	Refolding of proinsulins without addition of reducing agents
DE4405179A1 (de) *	1994-02-18	1995-08-24	Hoechst Ag	Verfahren zur Gewinnung von Insulin mit korrekt verbundenen Cystinbrücken
US5683987A (en) *	1994-07-12	1997-11-04	The Board Of Regents Of The University Of Nebraska	Therapeutic oligonucleotides targeting the human MDR1 and MRP genes
PT821006E (pt)	1996-07-26	2004-09-30	Aventis Pharma Gmbh	Derivados de insulina com ligacao a zinco aumentada
DE19735711C2 (de) *	1997-08-18	2001-04-26	Aventis Pharma Gmbh	Verfahren zur Herstellung eines Vorläufers von Insulin oder Insulinderivaten mit korrekt verbundenen Cystinbrücken
DE19825447A1 (de)	1998-06-06	1999-12-09	Hoechst Marion Roussel De Gmbh	Neue Insulinanaloga mit erhöhter Zinkbildung
DE19915938A1 (de)	1999-04-09	2000-10-19	Aventis Pharma Gmbh	Herstellung von pankreatischer Procarboxypeptidase B, Isoformen und Muteinen davon und ihre Verwendung
DE19930676B4 (de)	1999-07-02	2006-01-19	Sanofi-Aventis Deutschland Gmbh	Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
US7638618B2 (en)	2001-02-20	2009-12-29	Sanofi-Aventis Deutschland Gmbh	Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
US7202059B2 (en)	2001-02-20	2007-04-10	Sanofi-Aventis Deutschland Gmbh	Fusion proteins capable of being secreted into a fermentation medium
DE10235168A1 (de) *	2002-08-01	2004-02-12	Aventis Pharma Deutschland Gmbh	Verfahren zur Reinigung von Preproinsulin
AU2003280870A1 (en) *	2002-11-12	2004-06-03	Ckd Bio Corp.	Plasmids expressing human insulin and the preparation method for human insuling thereby
MY152979A (en)	2008-01-09	2014-12-15	Sanofi Aventis Deutschland	Novel insulin derivatives having an extremely delayed time-action profile
DE102008025007A1 (de)	2008-05-24	2009-11-26	Sanofi-Aventis Deutschland Gmbh	Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
DE102008003566A1 (de)	2008-01-09	2009-07-16	Sanofi-Aventis Deutschland Gmbh	Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
DE102008025008A1 (de)	2008-05-24	2009-11-26	Sanofi-Aventis Deutschland Gmbh	Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
DE102008003568A1 (de)	2008-01-09	2009-07-16	Sanofi-Aventis Deutschland Gmbh	Neue Insulinderivate mit extrem verzögertem Zeit-/ Wirkungsprofil
JP5695909B2 (ja)	2008-01-09	2015-04-08	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	極度に遅延した時間作用プロファイルを有する新規なインスリン誘導体
RS59913B1 (sr)	2008-10-17	2020-03-31	Sanofi Aventis Deutschland	Kombinacija insulina i glp-1-agonista
CN102596175A (zh)	2009-07-06	2012-07-18	赛诺菲-安万特德国有限公司	含有甲硫氨酸的水性胰岛素制备物
MY180661A (en)	2009-11-13	2020-12-04	Sanofi Aventis Deutschland	Pharmaceutical composition comprising a glp-1 agonist, an insulin and methionine
PT3345593T (pt)	2009-11-13	2023-11-27	Sanofi Aventis Deutschland	Composição farmacêutica compreendendo despro36exendina- 4(1-39)-lys6-nh2 e metionina
PL2611458T3 (pl)	2010-08-30	2017-02-28	Sanofi-Aventis Deutschland Gmbh	Zastosowanie AVE0010 do produkcji leku do leczenia cukrzycy typu 2
WO2012152439A1 (en)	2011-05-10	2012-11-15	Glucometrix Ag	Comprehensive buffer system for renaturing human proinsulin or proinsulin derivatives
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
AR087693A1 (es)	2011-08-29	2014-04-09	Sanofi Aventis Deutschland	Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2
TWI559929B (en)	2011-09-01	2016-12-01	Sanofi Aventis Deutschland	Pharmaceutical composition for use in the treatment of a neurodegenerative disease
JP5858945B2 (ja)	2012-03-15	2016-02-10	アークレイ株式会社	酵素を用いた測定方法
EP3229828B1 (en)	2014-12-12	2023-04-05	Sanofi-Aventis Deutschland GmbH	Insulin glargine/lixisenatide fixed ratio formulation
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
CA2998665A1 (en) *	2015-09-18	2017-03-23	Bionet Pharma Gmbh	Improvement of expression and folding in the manufacturing process of cd-rap by using a cd-rap precursor protein
JP7460182B2 (ja) *	2019-02-19	2024-04-02	ザ、トラスティーズオブプリンストンユニバーシティ	フォールディングされたドメインおよびｒｎａ顆粒会合タンパク質ドメインの光制御オリゴマー化および相分離のためのシステムおよび方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4366246A (en) *	1977-11-08	1982-12-28	Genentech, Inc.	Method for microbial polypeptide expression
US4431739A (en) *	1979-11-05	1984-02-14	Genentech, Inc.	Transformant bacterial culture capable of expressing heterologous protein
US4769326A (en) *	1980-02-29	1988-09-06	The Regents Of The University Of California	Expression linkers
US4652639A (en) *	1982-05-06	1987-03-24	Amgen	Manufacture and expression of structural genes
EP0195680A3 (en) *	1985-03-21	1987-06-10	Immunex Corporation	The synthesis of protein with an identification peptide
DE3526995A1 (de) *	1985-07-27	1987-02-05	Hoechst Ag	Fusionsproteine, verfahren zu ihrer herstellung und ihre verwendung

1990
- 1990-08-27 GR GR900100635A patent/GR1005153B/el not_active IP Right Cessation
- 1990-08-27 IL IL9549590A patent/IL95495A/en active IP Right Grant
- 1990-08-28 EP EP90912715A patent/EP0489780B1/en not_active Expired - Lifetime
- 1990-08-28 CA CA002065146A patent/CA2065146C/en not_active Expired - Lifetime
- 1990-08-28 PT PT95111A patent/PT95111B/pt not_active IP Right Cessation
- 1990-08-28 WO PCT/US1990/004840 patent/WO1991003550A1/en not_active Ceased
- 1990-08-28 KR KR1019920700456A patent/KR0159786B1/ko not_active Expired - Lifetime
- 1990-08-28 DE DE69032743T patent/DE69032743T2/de not_active Expired - Lifetime
- 1990-08-28 DK DK90912715T patent/DK0489780T3/da active
- 1990-08-28 IE IE312090A patent/IE903120A1/en not_active IP Right Cessation
- 1990-08-28 AT AT90912715T patent/ATE173018T1/de not_active IP Right Cessation
- 1990-08-28 HU HUP9200674A patent/HU216069B/hu unknown
- 1990-08-28 ES ES90912715T patent/ES2124216T3/es not_active Expired - Lifetime
- 1990-08-28 AU AU62872/90A patent/AU638277B2/en not_active Expired
- 1990-08-28 JP JP2512297A patent/JP3043803B2/ja not_active Expired - Lifetime
- 1990-09-28 ZA ZA906839A patent/ZA906839B/xx unknown
1992
- 1992-02-27 NO NO920774A patent/NO308667B1/no not_active IP Right Cessation
- 1992-02-28 FI FI920923A patent/FI113183B/fi active
2000
- 2000-05-03 CY CY0000013A patent/CY2168B1/xx unknown

Also Published As

Publication number	Publication date
ES2124216T3 (es)	1999-02-01
HK1012026A1 (en)	1999-07-23
HU216069B (hu)	1999-04-28
WO1991003550A1 (en)	1991-03-21
IL95495A (en)	1996-10-16
CA2065146A1 (en)	1991-03-01
CY2168B1 (en)	2002-08-23
FI920923A0 (fi)	1992-02-28
JP3043803B2 (ja)	2000-05-22
HU9200674D0 (en)	1992-08-28
KR0159786B1 (ko)	1998-11-16
NO920774D0 (no)	1992-02-27
NO920774L (no)	1992-04-28
PT95111B (pt)	1998-10-30
CA2065146C (en)	2002-07-23
HUT60327A (en)	1992-08-28
IL95495A0 (en)	1991-06-30
GR1005153B (el)	2006-03-13
EP0489780A4 (en)	1992-08-12
JPH05501799A (ja)	1993-04-08
AU638277B2 (en)	1993-06-24
ATE173018T1 (de)	1998-11-15
DE69032743T2 (de)	1999-06-17
IE903120A1 (en)	1991-03-13
DK0489780T3 (da)	1999-07-19
NO308667B1 (no)	2000-10-09
GR900100635A (el)	1991-12-30
FI113183B (fi)	2004-03-15
ZA906839B (en)	1991-06-26
DE69032743D1 (de)	1998-12-10
EP0489780A1 (en)	1992-06-17
EP0489780B1 (en)	1998-11-04
AU6287290A (en)	1991-04-08

Legal Events

Date	Code	Title	Description
1991-05-22	BB1A	Laying open of patent application	Effective date: 19901207
1998-10-30	FG3A	Patent granted, date of granting	Effective date: 19980709
2001-06-29	PC3A	Transfer or assignment	Free format text: 20010322 AVENTIS PHARMA DEUTSCHLAND GMBH DE
2013-07-17	MM4A	Annulment/lapse due to non-payment of fees, searched and examined patent	Free format text: MAXIMUM VALIDITY LIMIT REACHED Effective date: 20130709

Publication	Publication Date	Title
PT95111A (pt)	1991-05-22	Processo para a preparacao de proteinas de fusao
Walz et al.	1977	Amino acid sequence of human prothrombin fragments 1 and 2.
TW200516144A (en)	2005-05-16	Novel bone mineralization proteins, DNA, vectors, expression systems
ES8600780A1 (es)	1985-11-01	Materiales y metodos de exploracion y amplificacion en celulas hospedantes eucarioticas utilizando dihidrofolato-reduc- tasa resistente a metotrexato.
ATE46536T1 (de)	1989-10-15	Verfahren zur herstellung von reifen proteinen in wirtzellen von wirbeltieren.
ES540880A0 (es)	1986-05-16	Procedimiento para producir un fragmento de dna que compren-de un promotor de fosfatasa acida de levadura
DK13788D0 (da)	1988-01-13	Fremgangsmaade til fremstilling af et polypeptid
AU3461797A (en)	1998-02-10	Fas ligand-like protein, its production and use
IL173399A0 (en)	2006-06-11	Circular dna molecule with conditional origin of replication which contains nucleic acid of interest and selection marker but does not encode its replication initiation protein, method for preparing the same and use thereof in gene therapy
IL74972A (en)	1991-11-21	Atrial natriuretic/vasodilator polypeptides and process for the preparation thereof
PT955313E (pt)	2006-07-31	Nova proteina e processo para a sua producao
IL81018A (en)	1992-03-29	Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
PT96097A (pt)	1991-09-30	Processo para a preparacao de antigene de toxoplasma gondii bem como de meios de diagnostico, vacinas e anticorpos deles derivados
ATE419357T1 (de)	2009-01-15	Dna 19355 polypeptide, ein homolog des tumornekrosefaktors
ES8604309A1 (es)	1986-01-16	Un procedimiento para obtener un adn que codifica un factor de necrosis de tumor de conejo
EP0395706A4 (en)	1991-11-13	Production of gonorrheal pi proteins and vaccines
JPS6420095A (en)	1989-01-24	Polypeptide having anti-blood coagulating action
PT98669A (pt)	1992-07-31	Processo para a preparacao da estrutura proteica da toxina de gelonina vegetal
CY1106110T1 (el)	2011-06-08	ΜΕΘΟΔΟΣ ΠΑΡΑΣΚΕΥΗΣ ΕΝΟΣ ΠΕΠΤΙΔΙΟΥ ΜΕ pI ΠΑΝΩ ΑΠΟ 8 Ή ΚΑΤΩ ΑΠΟ 5
PT97427A (pt)	1992-01-31	Processo para a preparacao de proteinas de fusao de tendamistato em estreptomicetas
DE69634757D1 (de)	2005-06-23	Vektor zur expression von n-terminal verlängerten proteinen in hefezellen
ATE162853T1 (de)	1998-02-15	Menschlicher rekombinanter plazentaler ribonuklease-inhibitor und verfahren zur herstellung
ES553374A0 (es)	1987-05-16	Un procedimiento para mejorar la produccion de un polipeptido deseado en un hospedante transformado con una molecula de adn recombinantes.
EP0688224A4 (en)	1997-09-10	MUTANT PROTEIN, METHODS AND MATERIALS USED FOR ITS MANUFACTURE AND USE
IT1243286B (it)	1994-05-26	Processo per isolamento ed espressione del fattore neuronotrofico ciliare umano mediante la tecnologia del dna ricombinante.